Marc Tessier-Lavigne

DNLI

Marc Tessier-Lavigne serves as Director at Denali Therapeutics Inc. (DNLI). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

12 trades

$25.76M

Net Position

Net Seller

$25.76M

Companies Traded

DNLI

Active Period

Mar 2021 – Nov 2022

12 total trades

Most Recent

Sell DNLI

Nov 28, 2022 · $609.6K

Marc Tessier-Lavigne's Insider Trading at Denali Therapeutics Inc. (DNLI)

Buys

0 · $0.00

Sells

12 · $25.76M

Total Shares Bought

Total Shares Sold

477,509

DNLI Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 28, 2022↗	Sell	20,000	$30.48	$609.6K	1,870,360
Nov 3, 2022↗	Sell	20,000	$30.27	$605.5K	1,901,610
Sep 30, 2022↗	Sell	20,000	$30.82	$616.3K	1,914,780
Aug 25, 2022↗	Sell	20,000	$31.61	$632.3K	1,930,460
Jul 27, 2022↗	Sell	20,000	$35.61	$712.1K	1,950,560
Mar 25, 2022↗	Sell	20,000	$33.83	$676.6K	2,035,970
Dec 30, 2021↗	Sell	63,131	$44.43	$2.81M	96,398
Jun 8, 2021↗	Sell	94,378	$70.35	$6.64M	2,545,070
May 24, 2021↗	Sell	46,763	$60.11	$2.81M	2,551,100
May 5, 2021↗	Sell	3,237	$60.11	$194.6K	2,589,160
Apr 5, 2021↗	Sell	50,000	$56.62	$2.83M	2,628,070
Mar 3, 2021↗	Sell	100,000	$66.22	$6.62M	2,723,530